BBP

Virtus Biotech ETF

Jun 02 • 04:00PM ET

83.56

-0.91 -1.08 %

Financial • Exchange Traded Fund • USA • NYSE

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	49.45%	Total Holdings	62	Perf Week	-3.78%
Sponsor	Virtus ETF Solutions	ETF Type		Tags	equity	Return% 3Y	16.74%	AUM	76.05M	Perf Month	-1.65%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	10.27%	NAV/sh		Perf Quarter	2.41%
Index	LifeSci Biotechnology Products Index	Average Maturity		Tags	biotechnology	Return% 10Y		52W High	90.42 -7.59%	Perf Half Y	4.33%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	57.42 45.52%	Perf YTD	4.56%
Active/Passive		Quant Type		Tags	-	Flows% 1M	29.99%	Volatility	1.74% 1.55%	Perf Year	45.32%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	51.46%	ATR (14)	1.59	Perf 3Y	57.10%
Dividend Ex-Date	Dec 20, 2017	Dividend Type		Sector/Theme		Flows% YTD	64.74%	RSI (14)	41.00	Perf 5Y	62.82%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.57	Perf 10Y	190.54%
Expense	0.34%	Growth/Value		SMA20	-3.72%	Flows% 3Y		Rel Volume	1.57	Prev Close	84.47
Inverse/Leveraged		Market Cap		SMA50	-1.90%	Flows% 5Y		Avg Volume	10.17K	Price	83.56
IPO	Dec 17, 2014	Option/Short	Yes / Yes	SMA200	5.97%	Trades		Volume	15,937	Change	-1.08%

Mar-09-26 11:03AM	ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug (Benzinga)
Feb-17-26 09:44AM	Why Is ImmunityBio Stock Gaining Tuesday? (Benzinga)
Oct-30-25 09:00AM	Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
04:35AM	Loading…
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.80%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)

Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

open in yahoo | open in marketwatch | open in google

BBP

Virtus Biotech ETF

Upgrade your Finviz experience